These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 19124534)
1. Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. Ghezzi D; Viscomi C; Ferlini A; Gualandi F; Mereghetti P; DeGrandis D; Zeviani M Hum Mol Genet; 2009 Mar; 18(6):1058-64. PubMed ID: 19124534 [TBL] [Abstract][Full Text] [Related]
2. Myofibrillogenesis regulator 1 gene (MR-1) mutation in an Omani family with paroxysmal nonkinesigenic dyskinesia. Hempelmann A; Kumar S; Muralitharan S; Sander T Neurosci Lett; 2006 Jul; 402(1-2):118-20. PubMed ID: 16632198 [TBL] [Abstract][Full Text] [Related]
3. A case of familial paroxysmal nonkinesigenic dyskinesia due to mutation of the PNKD gene in Chinese Mainland. Liang S; Yu X; Zhang S; Tai J Brain Res; 2015 Jan; 1595():120-6. PubMed ID: 25107857 [TBL] [Abstract][Full Text] [Related]
4. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Lee HY; Xu Y; Huang Y; Ahn AH; Auburger GW; Pandolfo M; Kwiecinski H; Grimes DA; Lang AE; Nielsen JE; Averyanov Y; Servidei S; Friedman A; Van Bogaert P; Abramowicz MJ; Bruno MK; Sorensen BF; Tang L; Fu YH; Ptácek LJ Hum Mol Genet; 2004 Dec; 13(24):3161-70. PubMed ID: 15496428 [TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Bruno MK; Lee HY; Auburger GW; Friedman A; Nielsen JE; Lang AE; Bertini E; Van Bogaert P; Averyanov Y; Hallett M; Gwinn-Hardy K; Sorenson B; Pandolfo M; Kwiecinski H; Servidei S; Fu YH; Ptácek L Neurology; 2007 May; 68(21):1782-9. PubMed ID: 17515540 [TBL] [Abstract][Full Text] [Related]
6. Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability. Shen Y; Lee HY; Rawson J; Ojha S; Babbitt P; Fu YH; Ptácek LJ Hum Mol Genet; 2011 Jun; 20(12):2322-32. PubMed ID: 21487022 [TBL] [Abstract][Full Text] [Related]
7. A family with paroxysmal nonkinesigenic dyskinesias (PNKD): evidence of mitochondrial dysfunction. Ghezzi D; Canavese C; Kovacevic G; Zamurovic D; Barzaghi C; Giorgi C; Zorzi G; Zeviani M; Pinton P; Garavaglia B; Nardocci N Eur J Paediatr Neurol; 2015 Jan; 19(1):64-8. PubMed ID: 25453601 [TBL] [Abstract][Full Text] [Related]
8. Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD. Wang J; Zhao W; Liu H; He H; Shao R J Drug Target; 2018 Sep; 26(8):643-648. PubMed ID: 29103325 [TBL] [Abstract][Full Text] [Related]
9. Spinocerebellar ataxias type 27 derived from a disruption of the fibroblast growth factor 14 gene with mimicking phenotype of paroxysmal non-kinesigenic dyskinesia. Shimojima K; Okumura A; Natsume J; Aiba K; Kurahashi H; Kubota T; Yokochi K; Yamamoto T Brain Dev; 2012 Mar; 34(3):230-3. PubMed ID: 21600715 [TBL] [Abstract][Full Text] [Related]
13. Paroxysmal non-kinesigenic dyskinesia caused by the mutation of MR-1 in a large Polish kindred. Friedman A; Zakrzewska-Pniewska B; Domitrz I; Lee HY; Ptacek L; Kwiecinski H Eur Neurol; 2009; 61(1):39-41. PubMed ID: 18948699 [TBL] [Abstract][Full Text] [Related]
14. Paroxysmal non-kinesigenic dyskinesia due to a PNKD recurrent mutation: report of two Southern European families. Pons R; Cuenca-León E; Miravet E; Pons M; Xaidara A; Youroukos S; Macaya A Eur J Paediatr Neurol; 2012 Jan; 16(1):86-9. PubMed ID: 21962874 [TBL] [Abstract][Full Text] [Related]
15. Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients. Wang HX; Li HF; Liu GL; Wen XD; Wu ZY Chin Med J (Engl); 2016 May; 129(9):1017-21. PubMed ID: 27098784 [TBL] [Abstract][Full Text] [Related]
16. Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia. Lee HY; Nakayama J; Xu Y; Fan X; Karouani M; Shen Y; Pothos EN; Hess EJ; Fu YH; Edwards RH; Ptácek LJ J Clin Invest; 2012 Feb; 122(2):507-18. PubMed ID: 22214848 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of paroxysmal nonkinesigenic dyskinesia in Serbian family with Myofibrillogenesis regulator 1 gene mutation. Stefanova E; Djarmati A; Momcilović D; Dragasević N; Svetel M; Klein C; Kostić VS Mov Disord; 2006 Nov; 21(11):2010-5. PubMed ID: 16972263 [TBL] [Abstract][Full Text] [Related]
18. Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification. Erro R; Sheerin UM; Bhatia KP Mov Disord; 2014 Aug; 29(9):1108-16. PubMed ID: 24963779 [TBL] [Abstract][Full Text] [Related]
19. Effective Treatment of Paroxysmal Nonkinesigenic Dyskinesia With Oxcarbazepine. Kumar A; Szekely A; Jabbari B Clin Neuropharmacol; 2016; 39(4):201-5. PubMed ID: 27046658 [TBL] [Abstract][Full Text] [Related]